FDA clears Medtronic's MRI for neurosurgery

The FDA has granted 510(k) clearance for Medtronic’s PoleStar N30 Surgical MRI system for neuro-oncology surgical procedures. The company simultaneously launched the imaging system.

Providing imaging in the operating room, the PoleStar Surgical MRI seeks to provide surgeons with targeting and navigation for the anatomy movement that may occur during a surgical procedure, according to the Minneapolis-based Medtronic.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.